Last reviewed · How we verify
VIDAS® NEPHROCLEAR Diagnostic Accuracy Study
This is a multi-center sample analysis study in which urine samples previously collected from persons with Stage 2 or Stage 3 Acute Kidney Injury (AKI), will be tested in order to validate the VIDAS® NEPHROCLEAR™ CCL14 Test
Details
| Lead sponsor | BioMérieux |
|---|---|
| Status | COMPLETED |
| Enrolment | 477 |
| Start date | Mon Jul 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Thu Dec 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Acute Kidney Injury
- Stage 2 Acute Kidney Injury
- Stage 3 Acute Kidney Injury
Interventions
- VIDAS® NEPHROCLEAR™ CCL14 Test
Countries
United States